🇺🇸 FDA
Patent

US 8076352

Administration of carboline derivatives useful in the treatment of cancer and other diseases

granted A61KA61K31/4353A61K31/437

Quick answer

US patent 8076352 (Administration of carboline derivatives useful in the treatment of cancer and other diseases) held by PTC THERAPEUTICS, INC. expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4353, A61K31/437, A61K31/444, A61K31/5377